Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

Trial Profile

Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Aug 2014

At a glance

  • Drugs FE 992097 (Primary)
  • Indications Deglutition disorders; Prader-Willi syndrome
  • Focus Therapeutic Use
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 19 Aug 2014 Status changed from recruiting to completed as reported by the ClinicalTrials.gov.
    • 09 Apr 2014 Planned End Date changed from 1 Sep 2014 to 1 Aug 2014 as reported by the ClinicalTrials.gov.
    • 27 Jan 2014 Status changed from not yet recruiting to recruiting as reported by the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top